Related Experiment Video
Updated: Sep 15, 2025

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Long-term left ventricular ejection function in fulminant and non-fulminant myocarditis: A multicenter study in China
Guangling Li1, Jing Zhang2, Zheng Xu3
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan 430030, China.
Background:
There is a gap regarding comparisons of left ventricular ejection fraction (LVEF) changes between fulminant myocarditis (FM) and non-FM (NFM) patients at different follow-up intervals.
Methods:
This multicenter retrospective study included 324 patients (163 FM and 161 NFM) with confirmed acute myocarditis through endomyocardial biopsy (EMB) or cardiac magnetic resonance imaging. We used multi-model adjustment approach and a mixed-effects model to comprehensively evaluate changes in LVEF in FM relative to NFM, considering both dichotomous outcome (primary outcome) and repeated measurements outcome (secondary outcome). Sensitivity analysis was conducted for patients aged 15 years and older.
Results:
FM patients exhibited a higher risk of the primary outcome (LVEF < 55 % at the last two follow-up visits) compared to NFM patients, with an odds ratio (OR) of 8.517 (95 % CI, 4.666-16.552; P < 0.001). Following comprehensive adjustment for confounders, the OR for FM versus NFM was 7.438 (95 % CI, 3.967-14.763; P < 0.001). Analysis of repeated measurements (secondary outcome) revealed that LVEF in the NFM group surpassed that in the FM group at different follow-up time points. Consistent findings were observed in the sensitivity analysis population. Additionally, after adjusting for potential confounders, intra-aortic ballon pump (IABP) and extracorporeal membrane oxygenation (ECMO) demonstrated OR values of 0.030 (95 % CI: 0.002-0.197; P = 0.001) and 0.339 (95 % CI: 0.124-0.880; P = 0.030) in patients with FM, respectively.
Conclusion:
FM patients face a lower LVEF compared to NFM patients across various follow-up intervals. Additionally, early application of IABP and ECMO can enhance long-term LVEF in patients with FM.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management

